about
Underexpression of HOXA11 Is Associated with Treatment Resistance and Poor Prognosis in GlioblastomaStem Cells Transplantation and Huntington's DiseaseBrain response characteristics associated with subclavian steal phenomenon.MR Imaging Analysis of Non-Measurable Enhancing Lesions Newly Appearing after Concomitant Chemoradiotherapy in Glioblastoma Patients for Prognosis PredictionMultidrug resistance protein 1 reduces the aggregation of mutant huntingtin in neuronal cells derived from the Huntington's disease R6/2 modelNovel recursive partitioning analysis classification for newly diagnosed glioblastoma: A multi-institutional study highlighting the MGMT promoter methylation and IDH1 gene mutation status.Deleterious c-Cbl Exon Skipping Contributes to Human Glioma.Clinical Applications of Simultaneous PET/MR Imaging Using (R)-[11C]-Verapamil with Cyclosporin A: Preliminary Results on a Surrogate Marker of Drug-Resistant Epilepsy.Impact of interim progression during the surgery-to-radiotherapy interval and its predictors in glioblastoma treated with temozolomide-based radiochemotherapy.Prognosis prediction of non-enhancing T2 high signal intensity lesions in glioblastoma patients after standard treatment: application of dynamic contrast-enhanced MR imaging.c-Cbl regulates αPix-mediated cell migration and invasion.Soluble mediators from human neural stem cells play a critical role in suppression of T-cell activation and proliferation.Central nervous system complications after liver transplantation.Depletion of nerve growth factor in chemotherapy-induced peripheral neuropathy associated with hematologic malignanciesLight-induced amaurosis fugax due to severe distal internal carotid artery stenosis: in view of managing ocular ischemic syndrome.Galantamine reduces striatal degeneration in 3-nitropropionic acid model of Huntington's disease.Differentiation of High-Grade from Low-Grade Astrocytoma: Improvement in Diagnostic Accuracy and Reliability of Pharmacokinetic Parameters from DCE MR Imaging by Using Arterial Input Functions Obtained from DSC MR Imaging.Loss of Pericytes in Radiation Necrosis after Glioblastoma Treatments.Erratum to: Loss of Pericytes in Radiation Necrosis after Glioblastoma Treatments.Dysfunctional characteristics of circulating angiogenic cells in Alzheimer's disease.Heat-processed ginseng enhances the cognitive function in patients with moderately severe Alzheimer's disease.Dynamic contrast-enhanced MR imaging in predicting progression of enhancing lesions persisting after standard treatment in glioblastoma patients: a prospective study.Radiogenomics correlation between MR imaging features and major genetic profiles in glioblastoma.Circulating endothelial microparticles as a marker of cerebrovascular disease.Bortezomib treatment for severe refractory anti-NMDA receptor encephalitis.Tocilizumab treatment for new-onset refractory status epilepticusCerebral autoinflammatory disease treated with anakinra.Clinical and angiographic factors related to the prognosis of cavernous sinus dural arteriovenous fistulaDevelopment of LGI1 antibody encephalitis after treatment of lung cancerSurvival gain with re-Op/RT for recurred high-grade gliomas depends upon risk groupsAltered long noncoding RNA profile after intracerebral hemorrhageParadoxical Choroid Plexitis during Treatment for Tuberculous MeningoencephalitisPeriodicity of cerebral flow velocity during sleep and its association with white-matter hyperintensity volumeDevelopment of the clinical assessment scale in autoimmune encephalitisPrognostic Predictions for Patients with Glioblastoma after Standard Treatment: Application of Contrast Leakage Information from DSC-MRI within Nonenhancing FLAIR High-Signal-Intensity LesionsReply to "Grading the severity of autoimmune encephalitis: Advances and pitfalls"Dynamic Contrast-Enhanced MR Imaging of Nonenhancing T2 High-Signal-Intensity Lesions in Baseline and Posttreatment Glioblastoma: Temporal Change and Prognostic ValueEfficacy of atomoxetine versus midodrine for neurogenic orthostatic hypotensionComorbid Depression Is Associated with a Negative Treatment Response in Idiopathic REM Sleep Behavior DisorderPossible epigenetic regulatory effect of dysregulated circular RNAs in Alzheimer's disease model
P50
Q33584143-F93B7BF9-B493-48B7-9767-15AA50D7DA11Q33614689-D47A79F6-FFC9-41F9-8E91-556C30BAA895Q34656798-BACFDD4A-8550-4FB2-AB74-4E64FCBF96F4Q36189862-DBA2A313-DEDC-46D6-9F4D-C4516EE32BB1Q36301078-3AFC37D7-B167-4108-8C17-3622F72F9336Q36311375-6A6EAE0D-CC55-4F7A-B5AC-31330E3AFEE1Q36480205-C4000D8B-A390-493C-848C-A1400AA63609Q38420352-1251E6F3-EE62-4F6E-9D95-6376654A3BB3Q38678617-8399427A-B699-43F9-8349-D8F7FC139F6BQ38847085-AB8FB271-1D88-4910-B80C-896C0093CED1Q38934730-8676DA63-90B6-41AD-8C9A-99AC35C03E70Q39870471-D75208AC-C2E3-4C7B-B5B8-995169D27846Q40810827-2CD3E6EB-FCFF-44F1-AF93-BF754313C37FQ41475920-562D5DB6-573B-40E7-8A1A-9041A7E67C61Q43826008-40C33526-BE49-478D-90AC-BE8AF55381F6Q45291269-3F8A8637-BDF8-4508-BDF7-F8D40A24D2F9Q47246531-25C62ADB-CEC5-4EBF-B3D7-A1B12A838630Q47997045-37CFEF06-7E4E-49A9-A6F3-23D9C9F1C91DQ48098439-5E1CA6D9-0943-47FD-B97A-BFD6033CB384Q48263403-1E7A24BF-841B-436D-86C3-69E373705046Q50749785-7AA9BCE0-6557-4B65-86F4-846C7D2E8041Q51079367-E7D68746-DCA2-4A70-B5DA-B79C8E5AAB41Q53069279-84182427-00BD-4B34-9EE3-BF3C6E783D34Q53497260-0D37437D-EC94-4766-A617-B1BA09D60CC7Q55407957-1598BDB5-E96A-4C70-AE07-513AEABB60BFQ58574546-F364C3B3-F3A3-4BBB-A784-01C095F8A98FQ64974401-7AE91564-AD84-4F3B-B892-CDA4E41611BBQ82904848-78E0E0A9-641A-4FC4-BD6B-BB25D9BD27B5Q85915327-C4FA0C54-95AC-41B9-A257-FAB0C5D9A377Q89222312-0AA5F053-CED8-4FFF-8F54-B4FC4ABE0B50Q90307874-302B4FDA-5C27-48B3-961F-D4B207162DA1Q90579293-B07EE0F1-442D-4FD7-A4B4-377439B83F87Q90999592-F851635E-3F5E-4890-BB13-5B177750A59FQ91191724-6120D05F-45F9-49E0-8C01-D663355383B7Q91286109-3921A600-CAB2-478A-B7D4-F74CCACFC8E9Q91722883-69AA4926-46AA-45C3-9ABA-86A81022EBF4Q91733617-77E6FF6B-A92D-41F5-A68F-CC5E691B8ED5Q92125926-D9CEB288-DADE-4012-9EE1-571D41B7A331Q92140254-4214806A-B2F3-4336-8FF8-8A0DE25273A1Q92668853-270BD3F0-37FC-40FB-A7FD-F91168445D2C
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Soon-Tae Lee
@en
Soon-Tae Lee
@nl
type
label
Soon-Tae Lee
@en
Soon-Tae Lee
@nl
prefLabel
Soon-Tae Lee
@en
Soon-Tae Lee
@nl
P31
P496
0000-0003-4767-7564